article thumbnail

Sanofi snaps up acne vaccine developer Origimm Bio

pharmaphorum

The French group said that ORI-001, a vaccine based on recombinant proteins from the Cutibacterium acnes (formerly Propionibacterium acnes ) bacterium that is often found in acne lesions, could be the first ever vaccine for the condition.

article thumbnail

Pfizer and International Trachoma Initiative Deliver One Billionth Zithromax® Dose Toward Trachoma Elimination by 2030

Pfizer

Trachoma is a neglected tropical disease (NTD) caused by the bacterium Chlamydia trachomatis. An estimated 1.9 million people suffer visual impairment because of infection, and women are up to four times more likely to be blinded by trachoma than men. iii Zithromax is not approved in the United States or European Union to treat trachoma.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy. The company’s areas of focus include urology, immunology, cardiology, dermatology and infectious diseases. In 2022, Bayer’s revenue in the Pharmaceutical and Consumer Health sectors reached $26.68 Astellas Pharma Inc.

Sales 98